Loading company…
Illinois-based developer of therapeutics for central nervous system disorders, founded in 2006.
NeuroTherapeutics Pharma, Inc. develops compounds for central nervous system disorders, including neurological and neuropsychiatric conditions. Founded in 2006 and based in Chicago, US, the company raised Series A funding of USD 2.5 million in 2007 and Series B funding of USD 43 million in 2010, led by Fidelity Biosciences, MPM Capital Inc, SR One Capital Management and Pfizer Venture Investments. It raised USD 12 million in December 2011 and is recorded as having gone out of business in June 2013.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in